CliffBio
small molecule

PRIALT

ZICONOTIDE ACETATE

Loss of exclusivity—loss of exclusivity
CompanyEsteve →See this company's full patent-cliff portfolio

Drug detail

Brand namePRIALT
Active ingredientZICONOTIDE ACETATE
Strength500MCG/5ML (100MCG/ML)
Dosage formINJECTABLE
RouteINTRATHECAL
ModalitySmall molecule
FDA approvalDecember 2004
Marketing statusRX

More from Esteve

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PRIALT patent cliff — loss of exclusivity — | CliffBio